Work

Mechanism of Action and Translation to the Clinic of Detalimogene Voraplasmid (eg-70) – a Novel, Investigational Non-viral Immunotherapy for Non-muscle-invasive Bladder Cancer

Year: 2025

Type: article

Source: Urologic Oncology Seminars and Original Investigations

DOI: 10.1016/j.urolonc.2024.12.120

Authors: James C. Sullivan, Yair Lotan, Marie-Line Goulet, Shauna Dauphinee, Daniel Veilleux, Kristine Louis, David Lazure, Sarah Stevenson, Darius Bilimoria, Fazmina Zamzameer, Ximin Chen, Sebastien Sublemontier, Sahar Amirkhani, Carlos Fleet Carlos Fleet, Raj Pruthi, Anthony Cheung, Shreyas Joshi, Ashish M. Kamat

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4408018961

FWCI:

Cites:

Cited by:

Related to: 10